Renal cancer metastatic
Information
- Disease name
- Renal cancer metastatic
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03469713 | Completed | Phase 2 | Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma | July 14, 2017 | July 14, 2021 |
| NCT05215470 | Recruiting | Phase 2 | CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy | January 18, 2022 | November 30, 2026 |
| NCT05285579 | Recruiting | Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer | May 5, 2022 | August 2025 | |
| NCT03628859 | Unknown status | BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer) | December 21, 2018 | December 2023 | |
| NCT03736330 | Unknown status | Phase 2 | A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma | September 8, 2018 | November 8, 2021 |